Centocor

Results: 172



#Item
31UK DRAFFT - A randomised controlled trial of percutaneous fixation with kirschner wires versus volar locking-plate fixation in the treatment of adult patients with a dorsally displaced fracture of the distal radius

UK DRAFFT - A randomised controlled trial of percutaneous fixation with kirschner wires versus volar locking-plate fixation in the treatment of adult patients with a dorsally displaced fracture of the distal radius

Add to Reading List

Source URL: www.biomedcentral.com

Language: English
32Marketing Effectiveness  Best Total Integration Program for Large Companies The Award Sponsored by Everyday Health

Marketing Effectiveness Best Total Integration Program for Large Companies The Award Sponsored by Everyday Health

Add to Reading List

Source URL: media.mmm-online.com

Language: English - Date: 2013-05-21 21:24:23
33Centocor / Pilot plant / Canton of Schaffhausen / Technology / Business / Johnson & Johnson / Cilag / Pharmaceutical industry

DOC Document

Add to Reading List

Source URL: www.cilag.ch

Language: English - Date: 2008-06-18 12:21:49
34On June 1, 2005, the Federal Circuit affirmed the district court’s dismissal of MedImmune’s suit against Centocor seeking a declaration that U.S. Patent No. 5,807,715, which related to chimeric immunoglobulins, was i

On June 1, 2005, the Federal Circuit affirmed the district court’s dismissal of MedImmune’s suit against Centocor seeking a declaration that U.S. Patent No. 5,807,715, which related to chimeric immunoglobulins, was i

Add to Reading List

Source URL: www.law.umaryland.edu

Language: English - Date: 2005-06-07 12:02:25
35David P. Holveck was appointed President, Chief Executive Officer and a Director of Endo in April 2008 and retired as of March[removed]Mr. Holveck brought over 40 years of pharmaceutical industry expertise to Endo, and was

David P. Holveck was appointed President, Chief Executive Officer and a Director of Endo in April 2008 and retired as of March[removed]Mr. Holveck brought over 40 years of pharmaceutical industry expertise to Endo, and was

Add to Reading List

Source URL: www.sciencecenter.org

Language: English - Date: 2013-06-27 11:46:00
362013 Business Highlights Johnson & Johnson delivered strong results in 2013 led by the outstanding performance in our Pharmaceutical business, the relaunch and strength of key brands in our U.S. over-the-counter (OTC) an

2013 Business Highlights Johnson & Johnson delivered strong results in 2013 led by the outstanding performance in our Pharmaceutical business, the relaunch and strength of key brands in our U.S. over-the-counter (OTC) an

Add to Reading List

Source URL: 2013annualreport.jnj.com

Language: English - Date: 2014-03-07 15:21:20
37Sharps Disposal Plan for Janssen Biotech, Inc. (Janssen) Janssen Biotech, Inc. is a Johnson & Johnson (J&J) company. J&J is committed to the health and wellbeing of families everywhere. Our commitment is evident in the v

Sharps Disposal Plan for Janssen Biotech, Inc. (Janssen) Janssen Biotech, Inc. is a Johnson & Johnson (J&J) company. J&J is committed to the health and wellbeing of families everywhere. Our commitment is evident in the v

Add to Reading List

Source URL: www.janssenbiotech.com

Language: English - Date: 2014-01-16 10:51:28
38Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement

Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement

Add to Reading List

Source URL: www.janssen.com

Language: English - Date: 2014-11-14 09:39:18
39Multicounty Litigation – Levaquin Litigation – Reassigned from Atlantic to Middlesex

Multicounty Litigation – Levaquin Litigation – Reassigned from Atlantic to Middlesex

Add to Reading List

Source URL: www.judiciary.state.nj.us

Language: English - Date: 2014-11-05 13:41:44
40Cytokine and CAM Antagonists and Related Agents Therapeutic Class Review (TCR) September 22, 2014 No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, includ

Cytokine and CAM Antagonists and Related Agents Therapeutic Class Review (TCR) September 22, 2014 No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, includ

Add to Reading List

Source URL: www.hhsc.state.tx.us

Language: English - Date: 2014-11-05 17:48:09